Esperion Prepares for AHA Scientific Sessions
Esperion is excited to announce its participation in the upcoming American Heart Association (AHA) Scientific Sessions. The event, taking place in November, will feature a prestigious presentation in the Late Breaker/Featured Science Track along with three critical poster presentations aimed at enhancing understanding in cardiovascular health.
Highlighting Featured Science Presentation
One of the standout moments at this year's AHA Scientific Sessions will be a featured presentation focusing on the groundbreaking study titled Bempedoic Acid and Limb Outcomes in Statin-Intolerant Patients with Peripheral Artery Disease: New Insights from the CLEAR Outcomes Trial. This presentation aims to shine a light on vascular outcomes, showcasing new data that addresses the needs of statin-intolerant patients.
Details of the Featured Presentation
The featured science session is scheduled for November 18, where Dr. Marc P. Bonaca, a leader in the field, will share insights from this important research. Attendees can expect to learn about the implications of Bempedoic Acid in effectively managing peripheral artery disease and its broader impacts on cardiovascular health.
Poster Presentations Adding Value
Esperion will also unveil three compelling poster presentations during the AHA sessions. Each presentation aims to enrich the scientific dialogue around cardiovascular treatments and outcomes.
Liver Steatosis and Its Implications
The first poster presentation, titled Liver Steatosis and Liver Fibrosis Predict Major Adverse Cardiovascular Events in the CLEAR Outcomes Trial, will feature findings that identify liver health as a significant predictor of cardiovascular events. Dr. Diederick (Rick) Grobbee will present this vital research during the CVD Science Smorgasbord II session.
Managing Statin Intolerance
Another presentation will address the management challenges posed by statin intolerance due to muscle symptoms, titled Statin Intolerance due to Muscle Symptoms Affects Management of Patients: Insights from the CLEAR Outcomes Trial. This research emphasizes the need to adopt tailored approaches in treating patients at risk.
Effectiveness of Combination Therapies
Finally, Esperion will present findings on the Effectiveness of Lipid-lowering Therapy with Bempedoic Acid plus Ezetimibe in a Real-world Cohort. This moderated digital poster presentation will shed light on real-world effectiveness, facilitated by Dr. Evelyn Sarnes.
Commitment to Cardiovascular Health
Esperion Therapeutics is committed to advancing care for individuals with cardiovascular and cardiometabolic diseases. By bringing innovative solutions to the forefront, Esperion is dedicated to addressing the unmet health needs of millions living with high cholesterol. Their approach focuses on enabling healthcare providers to reduce LDL-cholesterol levels effectively, targeting patient goals and improving overall outcomes.
Connect with Esperion
For individuals seeking to learn more about Esperion and its commitment to revolutionizing cardiovascular healthcare, visiting their official websites can provide valuable insight. You can explore esperion.com or esperionscience.com for further details.
Frequently Asked Questions
What is the AHA Scientific Sessions?
The AHA Scientific Sessions is an annual conference focusing on the latest advancements in cardiovascular research and healthcare.
Who is the presenter of the featured science session?
Dr. Marc P. Bonaca will present the featured science session focused on Bempedoic Acid and its benefits for patients.
What topics will be covered in the poster presentations?
The poster presentations will cover liver health, statin intolerance, and lipid-lowering therapy effectiveness, among other relevant cardiovascular issues.
How does Esperion contribute to cardiovascular health?
Esperion develops innovative medicines aimed at improving outcomes for patients with cardiovascular diseases, particularly those struggling with high cholesterol.
Where can I find more information about Esperion?
Additional information can be found by visiting their websites or connecting on social media platforms like X.
